« Return to News | CROs/Service Providers

Parexel Cuts 2009 Guidance, Shares Fall 40%

Tuesday, October 28, 2008 12:23 PM

Waltham, Mass.-based contract research organization Parexel reduced its 2009 fiscal year guidance, and share prices plunged more than 40% to $8.05 in late morning trading.

Citing slower than expected sales in September and a negative impact from foreign exchange rates, the company lowered its full-year consolidated revenue guidance to $1.1 to $1.3 billion, down from $1.22 to $1.25.

“We anticipated a slowdown during the summer months, and then expected an acceleration of activity in September as has been typical in the past. Ultimately, however, sales performance for the quarter turned out to be short of target,” said Parexel chairman and CEO Josef H. von Rickenbach in a company statement.

Parexel reported service revenues of $263 million for the first quarter of fiscal year 2009, a 26.4% increase compared with the same period prior year, but net income for the quarter was down to $13.6 million from $13.9 million.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.